Successful trial of groundbreaking device, now approved by Nice, uses algorithm to determine amount of insulin neededPic: Six-year-old Charlotte ...
Protective Effect of Metformin on Venous Thrombosis in Diabetic Patients: Findings From a Systematic Review
Alqahtani S. et al., J Endocrinol Metab. 2022;12(6):161-167, doi: https://doi.org/10.14740/jem848Vascular disease including venous thromboembolis...
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR Preserved trial
Ref: Michael Böhm, European Heart Journal (2022) 00, 1–12, https://doi.org/10.1093/eurheartj/ehac693Empagliflozin reduced cardiovascular death an...
Lean Diabetes: A Unique form of Diabetes
Ref: Diabetes Care 2022;45:1428–1437 | https://doi.org/10.2337/dc21-1957IntroductionThe incidence of unique form of diabetes among individuals wi...
Continuous glucose monitoring (CGM) use increasing among young people, linked to lower HbA1c
Adapted from Endocrine Today ByErin T. Welsh, MA, Oct-19, 2022Use of continuous glucose monitoring among children and young adults with type 1 di...
Girls with type 1 diabetes may have worse cardiometabolic metrics than boys
Adapted from Endocrine Today By Erin T. Welsh, MA, Sept 23, 2022Source: de Vries SAG, et al. Abstract #469. Presented at: European Association fo...
Impact of Empagliflozin on Markers of Liver Steatosis and Fibrosis, and their Association with Cardiorenal Outcomes
Ref: Diabetes Obes Metab.2022;24:1061–1071, DOI: 10.1111/dom.14670IntroductionPatients with type-2 diabetes mellitus (T2DM) are predisposed...
Association of depression and parasympathetic activation with glycaemic control in type 2 diabetes mellitus (T2DM)
Ref: Kun-DerLin etal., Association of depression and parasympathetic activation with glycaemic control in type 2 diabetes mellitus, Journal of Di...
Rapid Progression of CKD in T2DM
Ref: Csaba P. Kovesdy, Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a pop...
Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin (The OMEGA study)
Ref: Ibrahim El Ebrashy, Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 di...